Показано 0 из 0
Дата |
---|
03.05.2024 |
29.04.2024 |
18.04.2024 |
17.04.2024 |
16.04.2024 |
15.04.2024 |
11.04.2024 |
10.04.2024 |
05.04.2024 |
04.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0072
|
0.0218
|
0.0218
|
0.0218
|
0.0218
|
0.0218
|
|
|
|
1.00
|
0.01
|
0.0299
|
0.022
|
0.022
|
0.022
|
0.022
|
|
|
|
1.00
|
0.0116
|
0.027
|
0.015
|
0.015
|
0.015
|
0.015
|
|
|
|
1.00
|
0.005
|
0.0313
|
0.0121
|
0.0116
|
0.0121
|
0.0116
|
|
|
3.63
|
3.00
|
0.01
|
0.035
|
0.025
|
0.025
|
0.025
|
0.025
|
|
|
|
1.00
|
0.005
|
0.027
|
0.028
|
0.028
|
0.028
|
0.028
|
|
|
|
1.00
|
0.01
|
0.0299
|
0.0126
|
0.0126
|
0.0135
|
0.0135
|
|
|
943.74
|
4.00
|
0.01
|
|
0.0153
|
0.0113
|
0.0153
|
0.0121
|
|
|
109.81
|
5.00
|
|
0.03
|
0.0164
|
0.015323
|
0.0164
|
0.015323
|
|
|
4.10
|
3.00
|
0.007
|
|
0.013
|
0.013
|
0.015
|
0.015
|
|
|
305.10
|
4.00
|
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.